Cancer Diagnosis Equipment & Supplies

What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal ...

A cancer diagnosis is stressful and overwhelming. We’re here to help. Understanding your genes can help guide you and your doctor to the most effective treatments, bringing you one step closer to beating cancer and then staying healthy in the long term. ...

Reducing Unnecessary Surgeries and Informing Treatment Decisions in Thyroid Cancer Diagnosis. The Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas (XA) provide physicians with a comprehensive solution for a complex landscape in thyroid cancer diagnosis and individualization of care. The combined offering enables ...

This compound capitalizes on the principle of metabolic trapping to use a radioactive tracer to directly evaluate the body's metabolic functions. FDG's utilization in whole-body PET imaging substantially enhances the capabilities for cancer diagnosis and staging, supports the selection of appropriate treatment options, and facilitates the evaluation of ...

The 4Kscore® Test is used by health care professionals to improve the accuracy of prostate cancer diagnosis after an abnormal prostate-specific antigen (PSA) test result, or digital rectal exam, before the decision is made to biopsy. The 4Kscore® Test provides a risk score (4KScore) for finding aggressive prostate cancer based on combined ...

MammoSOUND, based on our proprietary technology combines automated breast ultrasound with digital mammography allowing both imaging modalities in the same patient encounter and configuration for improved and efficient breast cancer screening and diagnosis. ...

The Decipher Prostate (Decipher Prostate Biopsy and Decipher Prostate RP) genomic classifier is a 22-gene, whole-transcriptome-developed test designed to help inform treatment decisions for men with localized prostate cancer at initial diagnosis and after surgical removal of the prostate. The test reports the Decipher Score, which prognosticates a patient's risk ...

Additionally, the system is built for user-friendly operations, allowing for comprehensive lesion assessment through labeling, measuring, and comparison tools, including 2D shear wave elastography for tissue elasticity assessment. The Invenia ABUS 2.0 stands as an imperative tool in providing personalized and comprehensive breast cancer screening and ...

This flexibility has allowed Starpharma to develop a range of DEP® radiotheranostics as well as its other DEP® programs. Radiotheranostics is a rapidly developing area of cancer treatment and diagnosis, and sales in this category are estimated to grow to $12–15 billion by 2030 (source: Nuclear medicine world market report & directory, ...

The company was founded by internationally recognized experts in prostate cancer, and an experienced management team, scientific advisory board, and board of directors with a track record of success. ...

Curasight has developed a novel and innovative Theranostics platform for improved cancer diagnose and treatment. The combination of using targeted radionuclide therapy to treat cancer, and a non-invasive PET imaging for diagnosing and monitoring, is known as Theranostics (Therapy + Diagnostics = Theranostics). Curasight’s solution combines the technologies ...

Prostate cancer is the only solid cancer still diagnosed through random sampling. Get accurate and meaningful results faster with a targeted approach. Thoughtfully engineered, the semi-robotic arm of the Fusion Bx allows you to effortlessly maneuver the probe to accurately locate and target suspicious regions of interest. ...

The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. According to the WHO, colorectal cancer is the third most common cancer worldwide, with approximately 1.9 million ...

The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. ...

Curasight's uTRACE is a uPAR-PET imaging and diagnostics technology. It is used to find, visualise, and predict whether a cancer is aggressive and if so, how it should be treated. uTRACE has been tested on over 400 patients in several cancer forms and proven to be ...

SERENYS DR is a full-field digital mammography solution for screening and diagnostic examinations supporting the prevention of breast cancer. Designed to ensure patient and operator comfort, it is implementable with a wide range of accessories including the device for stereotactic and tomoguided biopsies. Also available in a version not upgradable for biopsy exams: SERENYS DR ...

NuMedii has been pioneering the use of Big Data, Artificial Intelligence (AI) and systems biology since 2010 to accelerate the discovery of precision therapies to address high unmet medical needs. ...

Lung cancer remains a leading cause of death from cancer globally, due to its high incidence and late-stage diagnosis. Most patients are currently diagnosed with late-stage cancer, though research has shown 5-year survival rates are up to 10 times greater when disease is detected early. ...

Xilis is developing a panel of disease specific assays systematically testing the most important standard-of-care drugs within equipoise or difficult-decision settings to help clinicians and their patients make the most appropriate treatment decision for their unique cancer in a timely ...

The BT test is one of our newer Rapid Tests. Bladder Tumor or Cancer needs to be diagnosed as quickly as possible in order for treatment to be effective. The BT cassette test is an immunochromatographic rapid test for the qualitative detection of bladder cancer antigen (hcfHrp) in human urine. The test is intended to help to detect a bladder ...